µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© >nkVZ;tL
9~V'Wev
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© QFnuu-82"
1.Co-stimulators (or co-stimulating molecules) }8#olZ/(q
2.NK-kB )?{<Tt@
3.Immunoglobulin superfamily
%lj5Ol
j
4.antigen-presenting cell (APC) ?;tPqOs&
5.death domain 5 3pW:`
6.CCR and CXCR 56C8)?
7.Lectin (or mitogen) 3nA^s"#p
8.Clusters of differentiation, CD) bg~CV&]M
9.B7 family V_3oAu54s{
10.Cytotoxic T lymphocyte, CTL) 8cO?VH,nk
11.IL-15 and IL-15 receptor (IL-15R) >FE8CH!W&
12.MHC restriction {^oohW -
13.Affinity-chromatography 9swHa
14.Cyctosprin A, CsA feXo"J
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ]O;*Y{:Y
4$^mLD$>
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© tE0{ae
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 |2'WSAWG
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ J>R$K
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ |}{gE=]
R\cx-h*
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© w*{{bISw|
DWtITO>
ÃâÒßѧרҵ£º KS#A*BRQ
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ }S iR;2W
9ug4p'
]
Ïû»¯ÄÚ¿Æ£º cKYvNM
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ {zZ)JWM<w
[+FiD
ѪҺ²¡Ñ§×¨Òµ£º 0;x&\x7K
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿